Promoting Health for All Through Primary Health Care
Case Trackers
The novel coronavirus has rapidly spread across six continents. Since the first reported case in Wuhan, China, in December 2019, this infectious respiratory disease has expeditiously spread within China, neighboring countries and beyond. The number of confirmed cases and death toll caused by COVID – 19 worldwide are hastily increasing.
"Knowledge is Powerful. Information is Liberating."
~Kofi Anan
Creating a health literate society that is aware of the severity of the situation and is able to understand how to protect themselves, and others, through basic actions is fundamental for slowing the rate of the novel coronavirus infection.
Learn everything you need to know about COVID – 19. How is it transmitted? How does it affect the human body? What are the symptoms? And how do we protect ourselves and others?
We are debunking the Myths about COVID – 19 to help you better understand what is happening and cut through the confusion.
We provide you with helpful guidance on ways to address stressors caused by the life of quarantine and total lockdown.
We offer guidance on self-isolation at home.
Here are some tips on how healthy individuals can safely leave the house.
COVID – 19 Learning Resources
Here you can find more information and learning resources on preventing and managing COVID – 19.
Latest updates
News (English) – World Health Organization
- COVAX Announces new agreement, plans for first deliveries January 22, 2021COVAX announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer-BioNTech vaccine; rollout to commence with successful execution of supply agreements.Additionally, COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available in Q1 2021, via existing agreements […]
- GACVS COVID-19 Vaccine Safety subcommittee meeting to review reports of deaths of very frail elderly individuals vaccinated with Pfizer BioNTech COVID-19 vaccine, BNT162b2 January 22, 2021The GACVS COVID-19 Vaccine Safety subcommittee met virtually on Tuesday, 19 January 2021, to review available information and data on deaths reported in frail, elderly individuals who had received the Pfizer BioNTech COVID-19 mRNA vaccine, BNT162b2 (hereafter, BNT162b2). Experts invited from the European Medicines Agency (EMA) and the Uppsala Monitoring Center (UMC) provided an overview […]
